Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company ...

Glucagon-like peptide 1 receptor agonist treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms.

At least 18% of income protection claims came from the financial, professional, and support services sector, Mangaliso ...

A new device that monitors the waste-removal system of the brain may help to prevent Alzheimer's and other neurological ...

In what represents their first patenting, researchers from New York’s Stony Brook University filed for protection for development of a system and method that uses computer vision to analyze microscale ...

As the population ages, multimorbidity, or when a patient has multiple diseases at once, is becoming increasingly common. The ...

"I honestly cannot get a handle on how exactly to perform pain in an eminently believable way that means they will address it ...

Four months after Vertex Pharmaceuticals Inc.’s U.S. FDA nod for Journavx (suzetrigine) as the first drug targeting NaV1.8 for treating pain, Eli Lilly and Co. is joining the potential competition via ...

Researchers have identified a remarkably small but critical piece of genetic code that helps determine how brain cells connect, communicate, and function. The discovery not only deepens our ...

A new method developed by researchers at the Nuffield Department of Medicine, University of Oxford, could soon unlock the ...

Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Miami, FL) - fireside chat on Monday, June 9, 2025, at 10:00 a.m. Eastern Time. Interested parties may access the live and archived ...